Biocom at FCE Pharma Brazil: Deepening South American Market Presence, Collaborating with Partners for a Win-Win Future

Recently, the Biocom team traveled to São Paulo, Brazil, to participate in the 2026 FCE Pharma International Pharmaceutical Exhibition held from June 1 to 3 in São Paulo. As the largest and most influential pharmaceutical industry event in Latin America, this year's exhibition brought together pharmaceutical professionals from across the entire industry chain. The Biocom team engaged with colleagues from Latin America and around the world, conducting in-depth discussions on cutting-edge market demands, exchanging technical expertise, and exploring cooperation opportunities – injecting new momentum into our comprehensive cultivation of the Latin American pharmaceutical market and cross-regional pharmaceutical industry collaboration.

During the exhibition, the Biocom team upheld a professional and pragmatic service attitude, receiving a large number of industry clients and partners from Brazil and other Latin American countries. Recognizing the vast geographical expanse of the Brazilian and Latin American markets, the diversity of regulatory systems, and the prominent requirements for supply chain stability, product adaptability, and comprehensive service capabilities, the team showcased a range of core active pharmaceutical ingredients (APIs), intermediates, and integrated supporting solutions featuring stable processes and robust quality management systems. The two sides conducted multiple rounds of in-depth negotiations on key topics such as pharmaceutical registration and market access across Latin American countries, cross-border supply chain establishment, on-site quality audits, and regional market distribution, achieving fruitful communication outcomes. With our mature product portfolio and professional technical services, we have secured multiple collaboration intentions, made substantial progress in market expansion, and laid a solid foundation for the company's continued development in core Latin American markets.

Consistently adhering to the core values of "Integrity, Innovation, Responsibility, and Sharing," Biocom has built a comprehensive full-industry-chain pharmaceutical R&D and service platform integrating innovative drug R&D (Shanghai Beike Biotechnology), GMP standardized manufacturing base (Loncom Pharmaceuticals), and international registration & MAH operation services (Biocom). The company strictly follows ICH international guidelines while taking into account the differentiated regulatory requirements of various Latin American countries, striving to create high-quality products and services that are adaptable to global markets.

This visit to São Paulo for the exhibition was not only an efficient market expansion action but also an in-depth market research, technical benchmarking, and industry learning opportunity. Biocom sincerely thanks all clients and partners who visited our booth and gave us their trust and support! In the future, we look forward to continuing to work with partners from all sectors, leveraging our continuous innovation capabilities and outstanding "China Quality" to tackle industry development challenges together, deeply explore the potential of the Latin American pharmaceutical market, jointly draw a new blueprint for the coordinated development of the Latin American pharmaceutical industry, and contribute to global human health.